CMS Gives Most-Favored-Nation Pricing for Drugs a New Platform in Its Pilot “Generous Model” Program
In May 2025, President Trump issued Executive Order No. 14297, titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” calling on the pharmaceutical industry to ...
Enrolling in such a CMS-sponsored innovation model now has an added benefit: a new Anti-Kickback Statute (AKS) safe harbor. *This is the fourth article in a series analyzing recent updates to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback